A detailed history of Sigma Planning Corp transactions in Cor Medix Inc. stock. As of the latest transaction made, Sigma Planning Corp holds 39,947 shares of CRMD stock, worth $331,959. This represents 0.01% of its overall portfolio holdings.

Number of Shares
39,947
Previous 32,268 23.8%
Holding current value
$331,959
Previous $139,000 131.65%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$3.64 - $8.23 $27,951 - $63,198
7,679 Added 23.8%
39,947 $322,000
Q2 2024

Aug 05, 2024

BUY
$4.08 - $6.39 $3,851 - $6,032
944 Added 3.01%
32,268 $139,000
Q1 2024

May 01, 2024

BUY
$2.94 - $4.24 $92,092 - $132,813
31,324 New
31,324 $132,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $342M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.